Reforming direct-to-consumer advertising

Nat Biotechnol. 2011 May;29(5):397-400. doi: 10.1038/nbt.1865.
No abstract available

MeSH terms

  • Advertising / legislation & jurisprudence*
  • Advertising / standards*
  • Consumer Product Safety
  • Drug Industry / legislation & jurisprudence*
  • Drug Industry / standards*
  • Drug Prescriptions
  • Humans
  • Marketing / legislation & jurisprudence*
  • Marketing / standards*
  • Risk Factors
  • United States
  • United States Food and Drug Administration